Gregor Berger

8.0k total citations · 2 hit papers
130 papers, 5.3k citations indexed

About

Gregor Berger is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Gregor Berger has authored 130 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Psychiatry and Mental health, 26 papers in Physiology and 24 papers in Cognitive Neuroscience. Recurrent topics in Gregor Berger's work include Schizophrenia research and treatment (44 papers), Diet and metabolism studies (21 papers) and Fatty Acid Research and Health (19 papers). Gregor Berger is often cited by papers focused on Schizophrenia research and treatment (44 papers), Diet and metabolism studies (21 papers) and Fatty Acid Research and Health (19 papers). Gregor Berger collaborates with scholars based in Australia, Switzerland and Austria. Gregor Berger's co-authors include Patrick D. McGorry, G. Paul Amminger, Lisa Phillips, Alison R. Yung, Miriam R. Schäfer, Christos Pantelis, Stephen J. Wood, Claudia M. Klier, Barnaby Nelson and Shona M. Francey and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biological Psychiatry.

In The Last Decade

Gregor Berger

122 papers receiving 5.2k citations

Hit Papers

Long-Chain ω-3 Fatty Acids for Indicated Prevention of Ps... 2010 2026 2015 2020 2010 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregor Berger Australia 40 3.0k 988 966 920 918 130 5.3k
Daniël P. van Kammen United States 51 3.6k 1.2× 1.7k 1.7× 1.3k 1.4× 607 0.7× 1.0k 1.1× 218 7.6k
Marta Di Forti United Kingdom 45 3.3k 1.1× 1.1k 1.1× 1.3k 1.4× 540 0.6× 1.6k 1.8× 184 7.6k
Enric Álvarez Spain 44 1.7k 0.6× 934 0.9× 517 0.5× 380 0.4× 1.7k 1.9× 173 5.4k
Robert A. McCutcheon United Kingdom 31 2.7k 0.9× 1.5k 1.5× 1.3k 1.3× 371 0.4× 623 0.7× 118 6.4k
Romina Mizrahi Canada 45 2.3k 0.8× 1.2k 1.2× 1.9k 1.9× 405 0.4× 612 0.7× 155 6.8k
Wayne S. Fenton United States 38 5.5k 1.9× 1.5k 1.5× 593 0.6× 1.9k 2.1× 2.4k 2.6× 89 8.9k
Mara Parellada Spain 45 3.3k 1.1× 1.8k 1.8× 787 0.8× 358 0.4× 1.7k 1.8× 190 6.1k
Michael Riedel Germany 52 3.5k 1.2× 1.2k 1.2× 2.5k 2.5× 589 0.6× 1.3k 1.4× 219 9.7k
Ariel Graff‐Guerrero Canada 48 3.1k 1.1× 2.2k 2.2× 1.1k 1.2× 400 0.4× 719 0.8× 239 7.2k
Herbert Y. Meltzer United States 40 3.2k 1.1× 697 0.7× 1.2k 1.3× 493 0.5× 819 0.9× 60 5.9k

Countries citing papers authored by Gregor Berger

Since Specialization
Citations

This map shows the geographic impact of Gregor Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Berger more than expected).

Fields of papers citing papers by Gregor Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Berger. The network helps show where Gregor Berger may publish in the future.

Co-authorship network of co-authors of Gregor Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Berger. A scholar is included among the top collaborators of Gregor Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Berger. Gregor Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walther, Andreas, Rudolf Debelak, Clemens Kirschbaum, et al.. (2025). Major depressive disorder in children and adolescents is associated with reduced hair cortisol and anandamide (AEA): cross-sectional and longitudinal evidence from a large randomized clinical trial. Translational Psychiatry. 15(1). 183–183. 2 indexed citations
2.
Semple, T.J., et al.. (2025). The Body as a Battleground: A Qualitative Study of the Impact of Violence, Body Shaming, and Self-Harm in Adolescents with a History of Suicide Attempts. International Journal of Environmental Research and Public Health. 22(6). 859–859.
4.
Häberling, Isabelle, et al.. (2024). Inverse association between slow-wave sleep and low-grade inflammation in children and adolescents with major depressive disorder. Sleep Medicine. 119. 103–113. 3 indexed citations
5.
Baumgartner, Jeannine, Andreas Walther, Klaus Schmeck, et al.. (2024). Investigating thyroid function and iodine status in adolescents with and without paediatric major depressive disorder. British Journal Of Nutrition. 132(6). 725–737.
6.
Häberling, Isabelle, Suzanne Erb, Silke Bachmann, et al.. (2023). Sleep disturbance, but not depression severity, is associated with inflammation in children and adolescents. Journal of Clinical Sleep Medicine. 19(10). 1775–1784. 2 indexed citations
7.
Erb, Suzanne, et al.. (2023). Executive functions and borderline personality features in adolescents with major depressive disorder. Frontiers in Human Neuroscience. 17. 957753–957753.
8.
Willinger, David, Iliana I. Karipidis, Isabelle Häberling, et al.. (2022). Deficient prefrontal-amygdalar connectivity underlies inefficient face processing in adolescent major depressive disorder. Translational Psychiatry. 12(1). 195–195. 12 indexed citations
9.
Häberling, Isabelle, Gregor Berger, Klaus Schmeck, et al.. (2020). Verbal Memory Performance in Depressed Children and Adolescents: Associations with EPA but Not DHA and Depression Severity. Nutrients. 12(12). 3630–3630. 7 indexed citations
10.
Polari, Andrea, Suzie Lavoie, Hok Pan Yuen, et al.. (2018). Clinical Prediction Besides Transition to Psychosis in the Ultra-High Risk for Psychosis Population. Early Intervention in Psychiatry. 12. 2 indexed citations
11.
Kaiser, Stefan, Gregor Berger, Philippe Conus, et al.. (2018). Recommandations thérapeutiques de la SSPP pour le traitement de la schizophrénie. Forum Médical Suisse ‒ Swiss Medical Forum. 1 indexed citations
12.
Berger, Gregor, Stephen J. Wood, Margaret Ross, et al.. (2012). Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study. Current Pharmaceutical Design. 18(4). 570–575. 47 indexed citations
13.
Amminger, G. Paul, Miriam R. Schäfer, Κωνσταντίνος Παπαγεωργίου, et al.. (2010). Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders. Archives of General Psychiatry. 67(2). 146–146. 642 indexed citations breakdown →
14.
Garner, Belinda, Gregor Berger, Andrew Mackinnon, et al.. (2009). Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients. Schizophrenia Research. 113(1). 65–71. 30 indexed citations
15.
Pantelis, Christos, Gregor Berger, Warrick J. Brewer, et al.. (2008). Cross-sectional and longitudinal ventricular volume changes in chronic schizophrenia, first-episode psychosis, and ultra-high risk individuals. Biological Psychiatry. 63(7). 2 indexed citations
16.
Wood, Stephen J., Gregor Berger, Margaret Dell’Olio, et al.. (2007). Effects of low dose lithium on hippocampal neuropathology in people at ultra-high risk for psychosis. Biological Psychiatry. 61(8). 5 indexed citations
17.
Phillips, Lisa, Patrick D. McGorry, Belinda Garner, et al.. (2006). Stress, the hippocampus and the HPA axis: Implications for the development of psychotic disorders. Faculty of Health; Institute of Health and Biomedical Innovation. 6 indexed citations
18.
Brewer, Warrick J., Stephen J. Wood, Christos Pantelis, et al.. (2006). Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour. Psychiatry Research. 149(1-3). 97–104. 21 indexed citations
19.
Smesny, Stefan, et al.. (2005). Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids. 72(6). 393–402. 35 indexed citations
20.
Berger, Gregor, Stephen J. Wood, Christos Pantelis, et al.. (2002). Implications of lipid biology for the pathogenesis of schizophrenia. Australian & New Zealand Journal of Psychiatry. 36(3). 355–366. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026